Unity Biotechnology Statistics

Total Valuation

UBX has a market cap or net worth of $32.69 million. The enterprise value is $28.08 million.

Market Cap	32.69M
Enterprise Value	28.08M

Important Dates

The next estimated earnings date is Monday, April 14, 2025, before market open.

Earnings Date	Apr 14, 2025
Ex-Dividend Date	n/a

Share Statistics

UBX has 16.85 million shares outstanding. The number of shares has increased by 15.08% in one year.

Current Share Class	16.85M
Shares Outstanding	16.85M
Shares Change (YoY)	+15.08%
Shares Change (QoQ)	+0.20%
Owned by Insiders (%)	0.80%
Owned by Institutions (%)	11.49%
Float	14.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.31
P/TBV Ratio	2.31
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.45, with a Debt / Equity ratio of 1.73.

Current Ratio	3.45
Quick Ratio	3.31
Debt / Equity	1.73
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-28,257.00

Financial Efficiency

Return on equity (ROE) is -86.95% and return on invested capital (ROIC) is -34.44%.

Return on Equity (ROE)	-86.95%
Return on Assets (ROA)	-30.34%
Return on Invested Capital (ROIC)	-34.44%
Return on Capital Employed (ROCE)	-73.69%
Revenue Per Employee	n/a
Profits Per Employee	-$1.15M
Employee Count	19
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +6.01% in the last 52 weeks. The beta is 0.91, so UBX's price volatility has been similar to the market average.

Beta (5Y)	0.91
52-Week Price Change	+6.01%
50-Day Moving Average	1.67
200-Day Moving Average	1.49
Relative Strength Index (RSI)	48.69
Average Volume (20 Days)	203,338

Short Selling Information

The latest short interest is 460,421, so 2.73% of the outstanding shares have been sold short.

Short Interest	460,421
Short Previous Month	222,263
Short % of Shares Out	2.73%
Short % of Float	3.10%
Short Ratio (days to cover)	0.97

Income Statement

Revenue	n/a
Gross Profit	-18.39M
Operating Income	-28.26M
Pretax Income	-27.86M
Net Income	-21.89M
EBITDA	-27.36M
EBIT	-28.26M
Earnings Per Share (EPS)	-$1.32

Full Income Statement

Balance Sheet

The company has $29.04 million in cash and $24.43 million in debt, giving a net cash position of $4.61 million or $0.27 per share.

Cash & Cash Equivalents	29.04M
Total Debt	24.43M
Net Cash	4.61M
Net Cash Per Share	$0.27
Equity (Book Value)	14.14M
Book Value Per Share	0.84
Working Capital	21.48M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-22.54M
Capital Expenditures	n/a
Free Cash Flow	-22.54M
FCF Per Share	-$1.34

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

UBX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.08%
Shareholder Yield	-15.08%
Earnings Yield	-66.96%
FCF Yield	-68.94%

Analyst Forecast

The average price target for UBX is $7.00, which is 260.83% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	260.83%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 20, 2022. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Oct 20, 2022
Split Type	Reverse
Split Ratio	0.1:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a